D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Lindsay Corp
LNN
$1.14B
| $2.23M | ﹤0.01% |
23,278
+1,729
| +8% | +$158K |
|
2327
PUT
AMC Global Media
AMCX
$450M
| $2.22M | ﹤0.01% |
56,200
+29,400
| +110% | +$1.23M |
|
|
ECHO
2328
EchoStar
ECHO
$24.3B
| $2.22M | ﹤0.01% |
51,180
-97,006
| -65% | -$3.89M |
|
2329
Cheniere Energy
LNG
$54.2B
| $2.22M | ﹤0.01% |
36,282
+7,378
| +26% | +$454K |
|
|
TUP
2330
DELISTED
Tupperware Brands Corporation
TUP
| $2.21M | ﹤0.01% |
258,022
-659,304
| -72% | -$7.19M |
|
2331
CALL
Dover
DOV
$26.7B
| $2.21M | ﹤0.01% |
+19,200
| New | +$2.06M |
|
2332
Live Oak Bancshares
LOB
$1.98B
| $2.21M | ﹤0.01% |
116,372
+12,828
| +12% | +$237K |
|
2333
PUT
Forrester Research
FORR
$199M
| $2.21M | ﹤0.01% |
53,000
| – | – |
|
|
OSB
2334
DELISTED
Norbord Inc.
OSB
| $2.21M | ﹤0.01% |
+82,610
| New | +$2.2M |
|
2335
Cigna
CI
$78.4B
| $2.21M | ﹤0.01% |
10,786
-72,518
| -87% | -$13.3M |
|
|
ADVM
2336
DELISTED
Adverum Biotechnologies
ADVM
| $2.2M | ﹤0.01% |
19,116
-3,827
| -17% | -$337K |
|
2337
Orion Group Holdings
ORN
$368M
| $2.2M | ﹤0.01% |
424,226
+141,644
| +50% | +$703K |
|
2338
CALL
AppFolio
APPF
$6.62B
| $2.2M | ﹤0.01% |
+20,000
| New | +$2.04M |
|
2339
Ingles Markets
IMKTA
$1.72B
| $2.19M | ﹤0.01% |
46,206
-15,986
| -26% | -$681K |
|
|
JWN
2340
CALL
DELISTED
Nordstrom
JWN
| $2.19M | ﹤0.01% |
53,500
-32,000
| -37% | -$1.18M |
|
2341
PUT
Johnson & Johnson
JNJ
$640B
| $2.19M | ﹤0.01% |
15,000
-20,000
| -57% | -$2.71M |
|
2342
CALL
Ventas
VTR
$47.5B
| $2.19M | ﹤0.01% |
37,900
-33,800
| -47% | -$2.12M |
|
2343
Universal Health Services
UHS
$10.2B
| $2.19M | ﹤0.01% |
15,232
-10,068
| -40% | -$1.44M |
|
|
RAVN
2344
DELISTED
Raven Industries Inc
RAVN
| $2.19M | ﹤0.01% |
63,412
+35,844
| +130% | +$1.22M |
|
2345
CryoPort
CYRX
$753M
| $2.18M | ﹤0.01% |
132,664
-118,671
| -47% | -$1.77M |
|
|
FMBI
2346
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $2.18M | ﹤0.01% |
94,691
-142,044
| -60% | -$3.02M |
|
|
JAG
2347
DELISTED
Jagged Peak Energy Inc.
JAG
| $2.18M | ﹤0.01% |
+257,014
| New | +$1.88M |
|
2348
Matrix Service
MTRX
$312M
| $2.18M | ﹤0.01% |
95,228
-131,109
| -58% | -$2.59M |
|
|
BHVN
2349
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.18M | ﹤0.01% |
40,000
+10,000
| +33% | +$495K |
|
2350
ACI Worldwide
ACIW
$6.12B
| $2.18M | ﹤0.01% |
57,470
-57,201
| -50% | -$1.95M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.